Joel E . Schneider, M.D., F.A.C.C.

Return To Care Team



OFFICES


BIO

What Dr. Schneider loves most about being a cardiologist is that in an instant, he can impact a life. When he was a 7-year-old boy, his father awoke feeling poorly, yet insisted on taking his older brother Barry fishing as he had promised. Shortly thereafter, he collapsed on their cabin-cruiser and died suddenly from a heart attack at the age of 37. There was no treatment. Since this family tragedy in 1965, the field of cardiology has advanced rapidly, and Dr. Schneider has been privileged to be a part of many incredible advances.

In the early years of his training, he was only able to give morphine to calm the patient as he watched for complications of a damaged heart. As a medical resident, Dr. Schneider witnessed the first use of streptokinase, the so-called clot-buster medication, in an attempt to treat a patient in the midst of heart attack. Today, he works with a team of individuals who, within minutes of a patient’s arrival, assist him in opening a blocked artery with a coronary stent, essentially aborting a heart attack. Although he can never bring his father back, each patient and family he treats, using the wonderful advances over nearly 50 years, allows his father’s memory to live on through his work as a cardiologist.

Dr. Schneider’s family is his wife Cindy, his daughter Emily and his son Andrew. They enjoy traveling to Guatemala, where his wife started a non-profit organization, which includes a preschool for 16 children and supports tuition for over 75 students to attend their local schools. His daughter currently lives in Jerusalem, working with a human rights organization called Windows. Andrew attends Curry College outside Boston. Dr. Schneider especially enjoys time relaxing at the coast in their home in Beaufort, NC, swimming, boating and occasionally catching a fish. Despite spending much time within the walls of the hospital, the outdoors, whether hiking in the mountains or watching the Martins flying over the marshes, brings him much contentment.

FELLOWSHIP & POSTGRADUATE TRAINING

  • Fellowship, Cardiovascular Disease and Interventional Cardiology, Emory University Hospital, Atlanta, GA

INTERNSHIP/RESIDENCY

  • Residency: Internal Medicine, Strong Memorial Hospital, Rochester, NY

EDUCATION

  • Medical Degree: University of North Carolina at Chapel Hill
  • Undergraduate Degree: University of North Carolina at Chapel Hill

CERTIFICATIONS

  • Interventional Cardiology
  • Cardiovascular Disease
  • Internal Medicine

PROFESSIONAL MEMBERSHIPS

  • International Society for Endovascular Surgery
  • North Carolina Medical Society
  • Fellow, The American College of Cardiology
  • Fellow, Society of Cardiac Angiography and Intervention

SPECIALTIES

  • Percutaneous coronary intervention
  • Peripheral  vascular intervention
  • Abdominal aortic aneurysm repair 

  • PUBLICATIONS/PRESENTATIONS/RESEARCH

RESEARCH & PUBLICATIONS

  • Schneider JE, Kleinman MS, Kupeic JW. Cholestatic hepatitis after therapy with amoxicillin- clavulanate potassium. New York State Medical Journal. 1989;89:335-356.
  • Santoian EC, Gravanis MB, Karas SP, Anderberg K, Scott NA, Schneider JE, King SB. Use of the porous infusion balloon in swine coronary arteries: low pressure minimizes arterial damage (abstract). Circulation. 1991;84:4(suppl. II-70).
  • Santoian EC, Gravanis MB, Karas SP, Anderberg K, Schneider JE, Hearn JA, King SB. Enalapril does not inhibit intimal hyperplasia in a normolipemic swine model of intimal hyperplasia. Circulation. 1991;84:4(suppl II-591).
  • Schneider JE, Berk BC. Antioxidant therapy in coronary artery disease. Georgia American Heart Association Newsletter, 1992.
  • Santoian EC, Foegh M, Gravanis MB, Ramwell PW, Kot PA, Schneider JE, Anderberg K, King SB. Treatment with angiopeptin inhibits the development of smooth muscle cell proliferation in a balloon overstretch swine model of restenosis (abstract). J Am Col Cardiol. 1992;19:164A.
  • Schneider JE, Santoian EC, Gravanis MB, Cipolla GD, Anderberg K, King SB. Lovastatin fails to limit smooth muscle cell proliferation in normolipemic and hyperlipemic swine in an overstretch balloon injury model of restenosis (abstract). J Am Col Cardiol. 1992;19:163A.
  • Schneider JE, Gravanis MB, Santoian EC, Scott NA, Cipolla GD, Anderberg K, King SB. Repeat balloon injury markedly increases smooth muscle cell proliferations and alters the pattern of intimal hyperplasia in a swine model of restenosis (abstract). J Am Col Cardiol. 1992;19:163A,.
  • Schneider JE, Berk BC, Santoian EC, Gravanis MB, Cipolla GD, Tarazona N, Lassegue B, King SB. Probucol decreases the intimal proliferation in a swine model of coronary artery balloon injury: a possible role for antioxidants in restenosis. Circulation. 1992;88:628-637.
  • Santoian EC, Gravanis MB, Karas SP, Schneider JE, Anderberg K, Scott NA, King SB. Early and late development smooth muscle cell proliferation is not associated with thrombus formation in a balloon overstretch swine model of restenosis (abstract). Clinical Res. 1992.
  • Santoian EC, Gravanis MB, Karas SP, Anderberg K, Scott NA, Schneider JE, King SB. Porous balloon infusion of high dose heparin does not inhibit intimal hyperplasia in a normolipemic swine balloon injury model (abstract). Cath Cardiovasc Diag. 1992.
  • Santoian EC, Foegh M, Gravanis MB, Ramwell PW, Kot PA, Schneider JE, Anderberg K, King SB. Treatment with angiopeptin inhibits the migration and proliferation of smooth muscle cell proliferation in a balloon overstretch swine model of restenosis (abstract). Restenosis Summit IV, 1992.
  • Schneider JE, Berk BC, Santoian EC, Gravanis MB, Cipolla GD, King SB. Role of antioxidants in a swine model of restenosis (abstract). Restenosis Summit IV, 1992.
  • Santoian EC, Schneider JE, Karas SP, Gravanis MB, King SB. Differences in the patterns and extent of intimal hyperplasia in swine coronary arteries subjected to single balloon injury, double balloon injury, and endovascular stent placement (abstract). Restenosis Summit IV, 1992.
  • Schneider JE, Santoian EC, Gravanis MB, Cipolla GD, Scott NA, Tarazona N, King SB. Timing of repeat balloon injury influences the extent of intimal hyperplasia in a swine model of coronary restenosis (abstract). Restenosis Summit IV, 1992.
  • Cubeddu MG, Bowen J, Mann T, Schneider JE, Newman WN, Zellinger MJ, Rose GC, Arrowood ME. Clinical evaluation of current stent deployment strategies. J Invasive Cardiol. 1996: 8:1;41.
  • Schneider JE, Cubeddu MG, Mann T, Arrowood ME. Transradial coronary stenting: a single center US experience. J Invasive Cardiol. 1996;8:1;57.
  • Mann JT, Cubeddu G, Schneider JE, Arrowood ME. Right radial access for PTCA: a prospective study demonstrates reduced complications and hospital charges. J Invasive Cardiol. 1996; 8:Suppl D:40D-44D.
  • Mann JT, Cubeddu G, Schneider JE, Newman WN, Rose GC, Zellinger, MJ, Arrowood ME, Bowen J. Clinical evaluation of current stent deployment strategies. J Invasive Cardiol. 1996;8:Suppl D: 30D-35D.
  • Mann JT, Cubeddu G, Bowen J, Arrowood ME, Schneider JE. Comparison of clinical and economic outcomes of radial vs. femoral access sites in coronary stenting. Am J. Cardiol. 1997;29:Suppl A:416A.
  • Mann T, Cubeddu G, Bowen J, Schneider JE, Arrowood M, Newman WN, Zellinger MJ, Rose GC. Stenting in acute coronary syndromes: a comparison of radial versus femoral access sites. J Am Coll Cardiol. 1998;32:572-6.
  • Cubeddu R, Mann T, Schneider JE, Jobe L, Arrowood M. Factors in post-procedure myocardial infarction in coronary stenting: is guidewire time as important as anti-platelet strategy? Presentation at TCT meeting, 2000. Am J Cardiol. 2000;72i-73i.
  • Schneider JE, Mann T, Cubeddu MG, Arrowood ME. Transradial coronary stenting: a United States experience. J Invasive Cardiol. 1997;9:569-574.
  • Mann T, Cowper PA, Peterson ED, Cubeddu G, Bowen J, Giron L, Cantor WJ, Newman WN, Schneider JE, Jobe RL, Zellinger MJ, Rose GC. Transradial coronary stenting: comparison with femoral access closed with an arterial suture device. Catheter Cardiovasc Interv. 2000;49:150-6.
  • Mann T, Cubeddu G, Schneider JE, Arrowood M. Left internal mammary artery intervention: the left radial approach with a new guide catheter.J Invasive Cardiol. 2000;12:298-302.
  • Mann T, Cubeddu RJ, Raynor L, Bowen J, Schneider JE, Rose G, Cubeddu G, Ali Raza J, Jobe RL, Newman W, Zellinger M. Coronary stenting in stable patients: identification of a low-risk subgroup that may not require adjunctive anti-platelet therapy. Catheter Cardiovasc Interv. 2003;58:459-66.


go to top